eWEEK content material and product suggestions are editorially impartial. We might make cash if you click on on hyperlinks to our companions. Learn More.
FaceAge, a face-reading AI software that estimates organic age from facial pictures, predicts most cancers outcomes with a powerful 81% accuracy price. This surpasses conventional strategies and outperforms medical doctors in survival assessments.
Developed by researchers at Mass General Brigham, FaceAge exhibits early promise in predicting short-term life expectancy. The findings recommend the AI software can determine high-risk sufferers and supply a low-cost, accessible approach to inform care choices, enhancing medical decision-making.
How FaceAge interprets facial options into well being and age predictions
Trained on practically 59,000 photos of presumed-healthy adults aged 60 and older, FaceAge can determine delicate facial options related to getting old past apparent traits akin to hair coloring or balding.
Researchers examined FaceAge on 6,196 most cancers sufferers within the US and the Netherlands, and it persistently estimated their organic age to be about 5 years older than their precise chronological age. This signifies that, on common, most cancers sufferers appeared older by way of physiological getting old than their birthdate would recommend.
By analyzing facial options like wrinkles, pores and skin texture, and pigmentation, the AI software captures getting old markers invisible to the bare eye. It supplies a quantifiable measure of organic getting old that correlates with survival outcomes and well being dangers.
FaceAge vs. clinicians’ predictions
In testing, FaceAge outperformed clinicians in predicting short-term life expectancy for sufferers receiving palliative radiotherapy.
When 10 clinicians and researchers had been requested to estimate survival primarily based on 100 affected person pictures, their predictions had been solely barely higher than likelihood. Adding FaceAge knowledge, nevertheless, considerably improved accuracy, elevating prediction reliability from 61% to 80%.
Interestingly, the AI healthcare software alone surpassed medical doctors’ predictions, scoring 81%.
This enchancment was noticed throughout a number of most cancers sorts and phases, with FaceAge delivering a dependable prognostic sign, providing medical doctors extra goal and exact survival estimates.
Medical group weighs in on the AI software
FaceAge has drawn a mixture of cautious optimism and concern from medical consultants.
According to The Washington Post, Irbaz Riaz, assistant professor of medication and synthetic intelligence marketing consultant at Mayo Clinic, referred to as it “a promising early-stage tool.”
Hugo Aerts, director of the AI in Medicine program at Mass General Brigham and a lead researcher on the software, acknowledged its potential advantages however warned it might additionally trigger hurt if misused. He pressured that hospitals have strict guidelines and oversight to make sure AI is used correctly and solely to profit sufferers, not insurers or different events.
FaceAge’s broader potential
Mass General Brigham researchers say extra research are wanted earlier than FaceAge will be routinely utilized in medical settings. Their objective is to show it into an early detection system for numerous well being points, supported by robust moral and regulatory requirements.
Read eWeek’s protection of the high AI healthcare software program options.
